Vapreotide

	Vapreotide
Trade Name	Sanvar
Orphan Indication	Symptomatic carcinoid tumors
USA Market Approval	USA
USA Designation Date	2004-04-06 00:00:00
Sponsor	H3 Pharma, Inc.;666 Sherbrooke Street West Suite 1400, Montreal, Quebec,;